TR201102640T1 - Aztreonamın meropenem ve ertapenem adlı karbapenemlerle oluşturduğu sinerjik kombinasyonlar. - Google Patents

Aztreonamın meropenem ve ertapenem adlı karbapenemlerle oluşturduğu sinerjik kombinasyonlar.

Info

Publication number
TR201102640T1
TR201102640T1 TR2011/02640T TR201102640T TR201102640T1 TR 201102640 T1 TR201102640 T1 TR 201102640T1 TR 2011/02640 T TR2011/02640 T TR 2011/02640T TR 201102640 T TR201102640 T TR 201102640T TR 201102640 T1 TR201102640 T1 TR 201102640T1
Authority
TR
Turkey
Prior art keywords
ertapenem
meropenem
aztreonam
synergistic combinations
mrsa
Prior art date
Application number
TR2011/02640T
Other languages
English (en)
Inventor
Kasiviswanathan Kalyanasundaram
Original Assignee
Glade Organics Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glade Organics Private Limited filed Critical Glade Organics Private Limited
Publication of TR201102640T1 publication Critical patent/TR201102640T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Her biri yaklaşık o 25 g ila yaklaşık 0.75 g'lık dozaj aralığında karbapenem ve aztreonamı ve farmasötik olarak kabul edilebilir eksipiyenleri içeren, pseudomonas aeruginosa, acinetobacter baumannii, klebsiella pneumoniae veya mrsa'nm (metisiline 10 dirençli staphylococcus aureus) neden olduğu enfeksiyonların önlenmesine ve tedavisine yönelik farmasötik bir bileşim.
TR2011/02640T 2008-12-01 2009-12-01 Aztreonamın meropenem ve ertapenem adlı karbapenemlerle oluşturduğu sinerjik kombinasyonlar. TR201102640T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2510MU2008 2008-12-01

Publications (1)

Publication Number Publication Date
TR201102640T1 true TR201102640T1 (tr) 2011-08-22

Family

ID=42049533

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/02640T TR201102640T1 (tr) 2008-12-01 2009-12-01 Aztreonamın meropenem ve ertapenem adlı karbapenemlerle oluşturduğu sinerjik kombinasyonlar.

Country Status (6)

Country Link
US (1) US20110166119A1 (tr)
KR (1) KR20110095856A (tr)
DK (1) DK201170114A (tr)
TR (1) TR201102640T1 (tr)
WO (1) WO2010064261A1 (tr)
ZA (1) ZA201102232B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101912363A (zh) * 2010-07-29 2010-12-15 蔡海德 溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
ITFI20130203A1 (it) * 2013-08-30 2015-03-01 Univ Siena Metodo per la valutazione della sinergia tra prodotti antibiotici, e relativo kit di prodotti per l'attuazione di tale metodo
EP3354274A1 (en) * 2017-01-25 2018-08-01 SETLANCE S.r.l. Therapeutic combinations for the treatment of bacterial infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101410111B (zh) 2005-12-07 2012-12-12 巴斯利尔药物股份公司 单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用
KR101320718B1 (ko) * 2007-03-23 2013-10-21 바실리어 파마슈티카 아게 세균 감염 치료용 조합 약제

Also Published As

Publication number Publication date
ZA201102232B (en) 2012-07-25
KR20110095856A (ko) 2011-08-25
WO2010064261A1 (en) 2010-06-10
DK201170114A (en) 2011-03-09
WO2010064261A9 (en) 2010-09-16
US20110166119A1 (en) 2011-07-07

Similar Documents

Publication Publication Date Title
Kanagalingam et al. Practical use of povidone‐iodine antiseptic in the maintenance of oral health and in the prevention and treatment of common oropharyngeal infections
CY1114712T1 (el) Υδατικες φαρμακευτικες συνθεσεις περιεχουσες συμπλοκα βορικου-πολυολης
MA32784B1 (fr) Composes aryles substitues par heterocycle comme inhibiteurs de hif
TW200806300A (en) New therapeutic combinations for the treatment of depression
CL2012001250A1 (es) Compuestos derivados de espirooxoindol, antagonista de la interaccion entre p53 y mdm2; composición farmacéutica que lo comprende; a un kit farmacéutico; uso en el tratamiento del cancer.
EA201200253A1 (ru) Композиция для лечения муковисцидоза
BR112012028651A2 (pt) heterociclilbenzilpirazóis substituídos e uso do mesmo
BRPI0519013A2 (pt) composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto
HN2012000031A (es) Terapia de combinacion para el tratamiento de la diabetes
CR11418A (es) Trans-clomifeno para el sindrome metabolico
TW200734334A (en) Treatment of substance abuse
BR112015029367A8 (pt) combinação compreendendo oxazolidinonaquinolonas, seu uso, composição farmacêutica, e kit de partes
ES2421731T3 (es) Composición y procedimiento para el tratamiento de MRSA
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
MX2010002735A (es) Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.
MX2012005014A (es) Formulaciones de sulfoxido de dimetilo (dmso) y metilsulfonilmetano (msm) para tratar osteoartritis.
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
TR201102640T1 (tr) Aztreonamın meropenem ve ertapenem adlı karbapenemlerle oluşturduğu sinerjik kombinasyonlar.
PA8784901A1 (es) Utilizacion de un antagonista par1 en el tratamiento de la fibrilacion atrial
CY1111913T1 (el) Συνδυασμος σταθερης δοσης φυτικου αλατος και ψευδαργυρου
AR075041A1 (es) Composicion farmaceutica que contiene aleglitazar, proceso, uso.
BR112012005511B8 (pt) 5-(3,4-dicloro-fenil)-n-(2-hidróxi-ciclo-hexil)-6-(2,2,2-triflúor-etóxi-)-nicotinamida e sais da mesma como agentes de elevação de colesterol hdl
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
TW200806321A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
UY30284A1 (es) Compuestos de ariloxietilamina apropiados para tratar trastornos que responden a la modulacion del receptor de dopamina d3